Vethencourt, Andrea
Trinidad, Eva M.
Dorca, Eduard
Petit, Anna
Soler-Monsó, M. Teresa
Ciscar, Marina
Barranco, Alexandra
Pérez-Chacón, Gema
Jimenez, María
Rodríguez, Mario
Gomez-Aleza, Clara
Purqueras, Elvira
Hernández-Jiménez, Enrique
Urruticoechea, Ander
Morilla, Idoia
Subirana, Isaac
García-Tejedor, Amparo
Gil-Gil, Miguel
Pernas, Sonia
Falo, Catalina https://orcid.org/0000-0002-5714-6823
Gonzalez-Suarez, Eva
Funding for this research was provided by:
Instituto de Salud Carlos III (Rio Hortega contract CM19/00148)
Spanish Breast Cancer Research Group (Balil-Pelegrí grant 2021)
Ministerio de Ciencia, Innovación y Universidades (IJCI-2017-31564)
European Research Council (ERC 682935)
Amgen (ISS 20119112)
Article History
Received: 17 April 2024
Accepted: 7 March 2025
First Online: 12 May 2025
Declarations
:
: Informed consent was obtained from all subjects involved in the study.
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of the “Institut Català d’Oncologia de L’Hospitalet (ICO-L’Hospitalet)” (protocol code PR035/21)
: The authors declare no competing interests.